Resume-aware faculty matching

Find professors who actually fit you

Upload your resume. Four AI agents analyze your background, rank the faculty who fit, inspect their recent research, and help you draft outreach — grounded in their actual work, not templates.

Free to startNo credit cardCancel anytime
Top matches Balanced preset
Dr. Sarah Chen
Stanford · Interpretability · NLP
91
Dr. Marcus Holloway
MIT · Robotics · RL
84
Dr. Aisha Okonkwo
CMU · Fairness · HCI
82
Nova · Professor Researcher · re-ranking top 20…
Todd A. Miano

Todd A. Miano

University of Pennsylvania · Rehabilitation Medicine

Active 2006–2024

h-index23
Citations3.0k
Papers14382 last 5y
Funding$918k
See your match with Todd A. Miano — sign in to PhdFit.Sign in

About

Todd A. Miano, PharmD, PhD, is an Assistant Professor of Epidemiology in Biostatistics and Epidemiology at the Hospital of the University of Pennsylvania within the Perelman School of Medicine. His work as a critical care pharmacist and epidemiologist aims to reduce harm from adverse drug events in acutely ill patients. His research primarily focuses on understanding the determinants and impacts of nephrotoxicity, which is the rapid loss of kidney function caused by drug toxicity, and the health impacts of drug-drug interactions. Nephrotoxic acute kidney injury (AKI) is a significant, modifiable cause of AKI in hospitalized patients, especially in the context of polypharmacy, where multiple drugs can interact to increase toxicity risk. His research integrates observational causal inference studies, prospective molecular epidemiologic studies, and randomized clinical trials to examine the safety of nephrotoxic drugs and explore the molecular mechanisms underlying toxicity. Dr. Miano has advanced the understanding of phenotyping methods for nephrotoxic AKI, notably challenging the reliance on serum creatinine as a biomarker due to its poor sensitivity and specificity. His seminal work demonstrated that commonly prescribed antibiotics can cause false elevations in creatinine, leading to pseudo-nephrotoxicity, and proposed cystatin C as a more accurate biomarker for detecting kidney function changes during antibiotic treatment. His research has also shown that kidney disease significantly modifies the severity of drug-drug interactions mediated by hepatic metabolism inhibition, providing mechanistic insights into drug interactions encountered in clinical practice.

Research topics

  • Medicine
  • Internal medicine
  • Intensive care medicine
  • Anesthesia
  • Emergency medicine

Recent grants

Frequent coauthors

Education

  • Doctor of Philosophy (Epidemiology)

    University of Pennsylvania

    2019
  • Master of Science in Clinical Epidemiology

    University of Pennsylvania

    2015
  • PharmD, School of Pharmacy

    Virginia Commonwealth University

    2006

Similar researchers at University of Pennsylvania

  • Resume-aware match score
  • Save to shortlist
  • AI-drafted outreach

See your match with Todd A. Miano

PhdFit ranks faculty by your research interests, methods, and publications — grounded in their actual work, not templates.

  • Free to start
  • No credit card
  • 30-second signup